logo-loader
OncoCyte Corporation

OncoCyte releases positive data on lung cancer diagnostic study

OncoCyte Corporation (NYSE:OCX) CEO William Annett sat down with Proactive Investors at the BIO CEO & Investor Conference in New York.

Annett says recently, OncoCyte released positive data on its lung cancer diagnostic study.

Quick facts: OncoCyte Corporation

Price: $1.91

Market: NYSEMKT
Market Cap: $99.27 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Great Bear Resources releases more positive drill results...

Great Bear Resources (CVE: GBR) President and CEO Chris Taylor joined Steve Darling from Proactive Vancouver to discuss their latest assay results from the drill program on the Dixie Project in Red Lake.  Taylor discusser the results from the Hinge and Dixie Limb zones and also gave...

18 hours, 50 minutes ago

2 min read